5AM Venture Management, LLC - Q1 2023 holdings

$391 Million is the total value of 5AM Venture Management, LLC's 24 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 33.3% .

 Value Shares↓ Weighting
NewENLIVEN THERAPEUTICS INC$126,986,6035,798,475
+100.0%
32.47%
 ENTRADA THERAPEUTICS INC$63,921,496
+7.2%
4,408,3790.0%16.35%
+2.1%
VOR  VOR BIOPHARMA INC$34,226,070
-19.1%
6,361,7230.0%8.75%
-23.0%
SellRALLYBIO CORP$20,731,434
-15.4%
3,630,724
-2.7%
5.30%
-19.5%
CRNX  CRINETICS PHARMACEUTICALS IN$13,848,313
-12.2%
862,2860.0%3.54%
-16.5%
 DISC MEDICINE INC$12,469,086
+6.5%
588,4420.0%3.19%
+1.4%
IDYA SellIDEAYA BIOSCIENCES INC$11,924,780
-45.1%
868,520
-27.4%
3.05%
-47.8%
SCPH SellSCPHARMACEUTICALS INC$10,889,868
-44.5%
1,200,647
-56.1%
2.78%
-47.2%
FGEN BuyFIBROGEN INC$10,812,238
+199.2%
579,434
+156.9%
2.76%
+184.8%
RNA  AVIDITY BIOSCIENCES INC$10,216,269
-30.8%
665,5550.0%2.61%
-34.2%
ARVN  ARVINAS INC$8,742,400
-20.1%
320,0000.0%2.24%
-24.0%
COGT  COGENT BIOSCIENCES INC$8,528,848
-6.7%
790,4400.0%2.18%
-11.2%
ANAB  ANAPTYSBIO INC$7,784,270
-29.8%
357,7330.0%1.99%
-33.2%
VRDN SellVIRIDIAN THERAPEUTICS INC$7,123,200
-18.7%
280,000
-6.7%
1.82%
-22.6%
ISEE SellIVERIC BIO INC$6,924,951
-15.9%
284,626
-26.0%
1.77%
-20.0%
VKTX NewVIKING THERAPEUTICS INC$5,827,500350,000
+100.0%
1.49%
SPRB NewSPRUCE BIOSCIENCES INC$5,224,4402,364,000
+100.0%
1.34%
MRSN NewMERSANA THERAPEUTICS INC$4,870,3501,185,000
+100.0%
1.24%
PHVS  PHARVARIS N V$4,733,118
-28.4%
587,6000.0%1.21%
-31.9%
FIXX  HOMOLOGY MEDICINES INC$4,671,997
-18.3%
4,535,9190.0%1.20%
-22.2%
 PEAR THERAPEUTICS INC$4,269,749
-78.4%
16,744,1130.0%1.09%
-79.4%
IMPL  IMPEL PHARMACEUTICALS INC$4,038,707
-62.7%
2,884,7910.0%1.03%
-64.5%
CDTX  CIDARA THERAPEUTICS INC$1,440,829
+67.9%
1,134,5110.0%0.37%
+59.3%
NewMOONLAKE IMMUNOTHERAPEUTICSclass a ord$831,13038,856
+100.0%
0.21%
JANX ExitJANUX THERAPEUTICS INC$0-446,266
-100.0%
-1.58%
ExitCINCOR PHARMA INC$0-4,937,646
-100.0%
-16.31%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HOMOLOGY MEDICINES INC16Q3 202326.6%
ARVINAS INC16Q3 202314.3%
Crinetics Pharmaceuticals, Inc.16Q3 202312.8%
SCPHARMACEUTICALS INC16Q3 20237.5%
CIDARA THERAPEUTICS INC16Q3 20231.7%
IDEAYA BIOSCIENCES INC14Q1 202311.4%
VOR BIOPHARMA INC11Q3 202351.9%
CABALETTA BIO INC11Q2 202214.2%
AKOUOS INC10Q3 202227.7%
IMPEL PHARMACEUTICALS INC10Q3 20237.1%

View 5AM Venture Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-03
13F-HR2021-11-15

View 5AM Venture Management, LLC's complete filings history.

Compare quarters

Export 5AM Venture Management, LLC's holdings